MALIN CORPORATION PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.9 EUR | 0.00% |
|
+5.36% | +31.11% |
| 05-01 | Malin Corp investee signs agreement with Astellas Pharma | AN |
| 03-28 | Transcript : Malin Corporation plc - Shareholder/Analyst Call |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 121M | - | - | - | - | - | |
| 694B | ||||||
| 593B | ||||||
| 371B | ||||||
| 331B | ||||||
| 290B |
